TerminatedNCT06312657
Behavioral Effects of Drugs Inpatient 44 Neurobehavioral Mechanisms of Opioid Choice
Medication studyAges 18–50United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 50 years.
- Listed locations
- LexingtonSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 1, 2023
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 2
- Sponsor
- Joshua A. Lile, Ph.D.
- Sponsor type
- Individual investigator
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT06312657
- Official title
Show the full official title
Behavioral Effects of Drugs Inpatient 44: Neurobehavioral Mechanisms of Opioid Choice
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Lexington
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Joshua A. Lile, Ph.D.
Does this study involve medication?
Yes. The study involves medication, including Withdrawal and Remifentanil.
Who can participate?
Listed age limits: 18 years to 50 years.
Is this study still recruiting?
The registry lists this study as terminated.
